Advertisements

Kalpress Cardio

Quick links to important sections

Kalpress Cardio

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Kalpress Cardio

Kalpress Cardio is a prescription-only medication primarily used to manage high blood pressure and specific heart conditions, with its function defined by the active substance Valsartan. Its core identity is that of a synthetic cardiovascular agent, designed for systemic treatment via oral administration.

Property Description
Active ingredient Valsartan
Form Film-coated tablet; Oral suspension
Pharmacological class Angiotensin II Receptor Blocker (ARB)
Common use Management of high blood pressure
Origin Synthetic (Nonpeptide)

What Type of Medicine is Kalpress Cardio?

Kalpress Cardio is categorized as an Angiotensin II Receptor Blocker (ARB), which is a modern type of Antihypertensive Agent used to lower blood pressure and protect the cardiovascular system. The medication contains the sole active ingredient Valsartan (INN), a compound characterized as a potent, selective Angiotensin II receptor antagonist. This pharmaceutical product is typically presented for patient use as a film-coated tablet designed for oral administration.

The pharmacological class of ARBs is particularly clinically recognized because it offers a therapeutic mechanism distinct from ACE inhibitors, which limit the production of Angiotensin II. Valsartan instead directly and selectively blocks the AT1 receptor, facilitating the therapeutic goal of easing the strain on the heart and improving blood flow. The drug is indicated for use in managing hypertension and heart failure.


What is Valsartan Made Of and What is its Primary Purpose?

The Valsartan compound, the active component of Kalpress Cardio, is synthetic in origin and chemically identified as a nonpeptide tetrazole derivative. Its primary therapeutic purpose is to achieve systemic vasodilation and manage the body's Renin-Angiotensin-Aldosterone System (RAAS) to control elevated blood pressure (hypertension).

By managing the RAAS, the drug works by effectively blocking the signal that instructs blood vessels to constrict and tighten. Valsartan is a selective antagonist of the Angiotensin II AT1 receptor. This action translates into the general patient benefit of reducing the overall pressure within the arteries, thereby lessening the workload on the heart and supporting the long-term health of the circulatory system, especially in chronic conditions like diabetic kidney disease where ARBs are often utilized.

Advertisements

What side effects are possible with Kalpress Cardio?

Possible Side Effects and Safety Information

Adverse reactions associated with Kalpress Cardio are documented in official regulatory sources and are classified by how often they occurred in clinical studies and post-marketing surveillance.

Frequency-Classified Side Effects

Classification Examples of Reactions (Based on components)
Very Common Dizziness
Common Hypotension, Orthostatic Hypotension (low blood pressure upon standing), Diarrhea, Nausea, Vomiting, Fatigue, Cough, Increased Blood Creatinine
Uncommon Palpitations, Angina Pectoris, Dyspnea (shortness of breath), Hyperkalemia (high potassium levels)
Rare Angioedema (swelling), Rhabdomyolysis (muscle breakdown), Acute Renal Failure, Pancreatitis, Vasculitis

Serious Adverse Reactions and Key Safety Warnings

Serious Reactions identified in regulatory documentation include severe allergic reactions such as Angioedema, which presents as swelling of the face, tongue, and throat and requires immediate medical attention. Hepatic failure and Acute Renal Failure are also reported as rare, severe outcomes.

Fetal Toxicity (Pregnancy Risk): The medicine is strictly contraindicated during pregnancy. Its use during the second and third trimesters is documented to cause potential fetal harm, including reduced fetal kidney function, low amniotic fluid (oligohydramnios), and risk of neonatal death.

Safety Restrictions and Monitoring: Official documentation advises caution and monitoring for specific risks, including the potential for Hyperkalemia (high potassium in the blood) and worsening Renal Function in susceptible patients. Caution is also noted for severe Hypotension (low blood pressure), which is more likely to occur in patients who are volume- or salt-depleted before starting treatment.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Scope: Recognized Clinical Manifestations

System Documented Presentations
Cardiovascular Irregular or slow heart rhythms, shock (extremely low blood pressure), and generalized weakness.
Gastrointestinal Nausea, vomiting, diarrhea, loss of appetite, and stomach pain.
Neurological Confusion, headache, drowsiness, fainting, lethargy, and hallucinations.

Overdose Risk Factors

An overdose occurs when a person takes more than the normal or recommended amount of this medication, which may be either accidental or intentional. A particular risk is associated with long-term (chronic) poisoning, which is especially likely to affect older individuals, particularly those with existing kidney problems or dehydration. In severe cases, reduced heart function and heart rhythm disturbances can lead to poor outcomes, and death has been reported, especially in older adults and young children.

Emergency Response Instructions

Immediate medical help is required in the event of a suspected overdose. Call your local emergency number or Poison Control Center right away.

Do not attempt to make the person vomit unless a healthcare provider or poison control center explicitly instructs you to do so. Be prepared to provide the person’s age, weight, condition, the name and strength of the product, the time it was swallowed, and the amount taken.

Advertisements

Therapeutic Uses of Kalpress Cardio

What Kalpress Cardio Treats: Main Uses and Benefits

Kalpress Cardio is a cardiovascular support used across domains where additional symptomatic support is needed for conditions presenting with symptoms that create noticeable physiological strain on the heart and circulatory system.

The medication is commonly used to manage chronic high blood pressure (hypertension), conditions involving episodic or fluctuating manifestations of heart failure, and conditions involving a weakened heart after a heart attack. It is also considered relevant for addressing diabetic nephropathy in high-risk patients. This supportive approach assists with functional stability and contributes to easing the overall symptom load.

The treatment is applied in clinical settings that involve chronic or unstable symptom patterns. For instance, in heart failure, it helps address symptom clusters that may become intense or disruptive. The supportive relief offered by this medication supports general well-being during symptomatic phases and supports patients during difficult episodes by easing distress.


Quick Fact: Relief for Systemic Pressure Strain

Regulatory References

  1. Valsartan: MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Kalpress Cardio — Official Regulatory Information

The eligibility for using Kalpress Cardio (Valsartan) is strictly governed by authoritative regulatory documents.


Category Official Regulatory Statement
Populations for whom use is allowed (as stated in label) Adults for all approved indications (hypertension, heart failure, post-myocardial infarction); Pediatric patients ge 1 year of age for hypertension (US labeling) or ge 6 years (EU labeling).
Populations for whom use is contraindicated Women in the Second and Third Trimesters of Pregnancy; Patients with known Hypersensitivity to Valsartan; Patients with Severe Hepatic Impairment, Biliary Cirrhosis, or Cholestasis; Patients with Diabetes Mellitus concomitantly receiving Aliskiren.
Populations for whom use is not recommended Infants <1 year of age (for hypertension); Children and adolescents <18 years of age (for heart failure or post-myocardial infarction); Breastfeeding women; Patients with Primary Hyperaldosteronism.

Eligibility Classifications

Classification Official Definition (as defined in official documents)
Eligibility severity classification Contraindicated (e.g., Late-Stage Pregnancy); Not Recommended (e.g., Infants <1 year); Conditional Use (e.g., Mild-to-Moderate Hepatic Impairment).
Eligibility-context constraints Exclusion based on Physiological State (Pregnancy); Exclusion based on Comorbidity Severity (Severe Hepatic Impairment); Exclusion based on Concomitant Drug Use (Aliskiren in Diabetes).

Resulting Eligibility Structure

The official regulatory profile strictly defines patient eligibility through absolute contraindications relating to specific physiological states and severe pre-existing comorbidities. Furthermore, limitations are established for age groups and require conditional use based on organ function (e.g., renal and hepatic impairment) as stated in the prescribing information.

Advertisements

What should I know about interactions with other medicines?

Kalpress Cardio (valsartan) can interact with certain other medicines and products, potentially increasing the risk of adverse effects such as high potassium levels (hyperkalemia) or reduced kidney function.

Combinations to Discuss with Your Healthcare Provider

Agents that Increase Potassium: Concomitant use with potassium-sparing diuretics (water pills), potassium supplements, or salt substitutes containing potassium is generally not recommended due to the significant risk of hyperkalemia. Monitoring of potassium levels is necessary if this combination is unavoidable.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Combining Kalpress Cardio with NSAIDs (e.g., ibuprofen, naproxen) may lead to a decrease in the medicine's blood-pressure-lowering effect and can increase the risk of kidney function problems, especially in patients with existing kidney impairment or those who are elderly.

Other Blood Pressure Agents (Dual RAS Blockade): The simultaneous use of Kalpress Cardio with ACE inhibitors (another class of blood pressure medicine) or with aliskiren is typically not recommended. In patients with diabetes or moderate-to-severe kidney impairment, the use of Kalpress Cardio with aliskiren is contraindicated (should not be used) due to heightened risks of low blood pressure, hyperkalemia, and kidney deterioration.

Lithium: If you are taking lithium for a mental health condition, Kalpress Cardio may cause increased levels of lithium in your blood, raising the risk of toxicity. Your lithium levels will require close monitoring.

Advertisements

Mechanism of Action

Selective Blockade of the Renin-Angiotensin System's Primary Receptor

The drug's mechanism involves antagonism of the Angiotensin II type 1 ( AT1) receptor, which prevents the signaling effects of Angiotensin II ( AngII). This AT1 receptor is located on the surface of cells in the blood vessels, heart, and kidneys. This suppression of AngII signaling initiates a cascade that results in the physiological consequence of vasodilation.

Dampening Vasoconstriction and Aldosterone Signaling

The medication modifies molecular steps in pathways where vasoconstrictive mediators dominate. By preventing AngII from binding to AT1, the drug suppresses signals that cause blood vessels to contract and simultaneously reduces the release of aldosterone from the adrenal glands. This dual action results in a decrease in systemic vascular resistance and overall blood pressure.

Influencing Chronic Organ Remodeling Signals

The mechanism is active in systems that influence long-term tissue structure. Its action involves the suppression of AT1 signaling, which influences molecular pathways involved in fibrosis and hypertrophy (remodeling) within heart and kidney tissue.

Advertisements

Dosage and Administration Information

How to Use Kalpress Cardio

Kalpress Cardio is an oral medication, containing the active substance Valsartan. It may be taken with or without food.


Administration and Dosing

The medication is available as film-coated tablets in multiple strengths and may also be prepared as an oral suspension for certain patients. The dosing frequency and amount are determined by the condition being treated:

Indication Starting Dose Frequency Maximum Dose (Total Daily)
Adult Hypertension 80 mg or 160 mg Once daily 320 mg
Adult Heart Failure 40 mg Twice daily 320 mg
Adult Post-MI 20 mg Twice daily 320 mg

Procedural and Adjustment Guidance

The dosage for chronic conditions like Heart Failure is subject to a titration protocol, where the dose is incrementally adjusted at intervals of at least two weeks to achieve the target maintenance dose. For Post-Myocardial Infarction treatment, administration may begin as early as 12 hours after the event, with dose adjustment proceeding over the initial weeks.

Specific administration conditions apply to non-standard formulations: the oral suspension and the tablets are not milligram-for-milligram substitutable due to differing systemic exposure, necessitating a dose adjustment when switching forms. Furthermore, while no initial dose adjustment is typically required for older adults or those with mild-to-moderate renal impairment, it is recommended that the total daily dose for patients with mild-to-moderate hepatic impairment not exceed 80 mg.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Kalpress Cardio

Evidence for use in High Blood Pressure (Hypertension)

Research for this use involves many large-scale randomized controlled trials (RCTs) exploring the use of Valsartan in adults with elevated blood pressure and high cardiovascular risk. The studies monitored outcomes such as the achievement of target blood pressure measurements and the subsequent recording of major cardiovascular events, including stroke and heart failure.

Long-term trials reported measurements of cardiac event rates that were described as similar between the Valsartan group and the comparator group over the full study duration. Some trials reported patterns where the observed incidence of new-onset diabetes varied between the Valsartan group and the group taking a calcium channel blocker. Data for long-term outcomes specifically in the pediatric population are not as fully established as they are for adults.


Evidence for use After a Heart Attack (Post-Myocardial Infarction)

The evidence base relies on dedicated, large-scale RCTs, which included patients enrolled shortly after experiencing an acute myocardial infarction (heart attack) complicated by signs of heart failure or reduced heart function. These studies monitored primary endpoints related to death (all-cause mortality) and the recording of major cardiac events.

Recorded measurements in the Valsartan monotherapy group were described as similar to those in the ACE inhibitor monotherapy group. Research also explored the use of Valsartan in combination with an ACE inhibitor. What remains uncertain is whether the evidence is sufficient for the combination approach, as the study reports documented that the monitored outcomes were inconclusive when combining the two treatments, indicating limitations for this regimen.


Evidence for use in Diabetic Kidney Disease (Diabetic Nephropathy)

Valsartan was evaluated in patients with Type 2 Diabetes Mellitus who showed signs of early kidney damage. Research monitored the change in levels of albuminuria (a key biomarker) and tracked the rate of decline in overall kidney function.

Studies reported that albuminuria measurements were numerically reduced in the Valsartan groups compared to other therapies or placebo. This pattern was observed even in trials where Valsartan was administered at a low dose that did not produce a significant change in systemic blood pressure levels. The long-term effects on end-point outcomes for kidney health in diabetic patients are often inferred from changes in biomarkers due to the demanding duration required for studies of actual end-stage kidney disease progression.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Kalpress Cardio (FAQ)


Q: Does Kalpress Cardio need to be taken at the exact same time every day?

Official guidance in the patient information suggests that this medicine is typically taken at the same time every day. Taking it consistently helps maintain stable levels of the medication in your body, which supports the management of your condition.


Q: How long does it usually take to notice an effect from Kalpress Cardio?

The initial blood pressure-lowering effect typically begins about two hours after you take a single dose. Official studies indicate that it may take approximately four weeks of repeated daily dosing before the maximum or full blood pressure reduction is achieved. The four-week mark is often a key period for assessing the medication's effect.


Q: Is there a certain kind of food or drink that I should avoid while taking Kalpress Cardio?

Official product information advises caution regarding the use of potassium-containing salt substitutes or potassium supplements. This is because the medication itself may contribute to increasing potassium levels in the blood (a condition called hyperkalemia), and adding these products may heighten that risk.


Q: If I miss a dose of Kalpress Cardio, is there anything I need to know?

If a person realizes a dose was missed, patient information suggests taking it as soon as possible. If it is already very close to the time for the next scheduled dose, only the single upcoming dose should be taken. Patient information states that an individual should not take double or extra doses to compensate for a missed dose.


Q: Can Kalpress Cardio affect my ability to drive or operate machinery?

Official safety information notes that this medicine can cause side effects such as dizziness or fatigue, particularly when treatment is initiated or after a dose is changed. If these effects occur, the ability to drive or operate complex machinery may be affected.


Q: What happens if I accidentally take two doses of Kalpress Cardio close together?

Accidental overdose is associated with signs of pronounced low blood pressure (hypotension) and possible severe dizziness. Regulatory documents recommend immediately seeking medical assistance, such as contacting a poison control center or emergency room.


Q: Does taking Kalpress Cardio mean I don't have to watch my diet anymore?

The medication is part of a comprehensive treatment plan for chronic conditions. Official sources suggest that the medication is generally used in combination with appropriate diet and healthy lifestyle changes, as the medicine does not replace these changes.


Q: Can a person stop taking Kalpress Cardio suddenly without a problem?

The medication should only be stopped under the supervision of a healthcare professional. If use is discontinued without guidance, the underlying condition, such as high blood pressure, may return or worsen.


Q: Is there any evidence about Kalpress Cardio and long-term organ health?

Studies examined the use of the drug for extended periods to gather data on long-term health outcomes. Research evidence includes monitoring for major cardiovascular events in patients over periods of up to two years, demonstrating the treatment's sustained effect when used for chronic conditions.


Q: Are there known interactions between Kalpress Cardio and common pain relievers?

Official warnings exist regarding the combination with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which may lessen the medication's effect and increase the risk of kidney problems. However, regulatory interaction data generally show no significant issue with standard pain relievers like acetaminophen.


Q: Why is Kalpress Cardio sometimes prescribed for conditions other than high blood pressure?

Regulatory documents confirm that this medicine is approved for the management of high blood pressure (hypertension) as well as for the treatment of heart failure and for specific use in patients who have recently experienced a heart attack (post-myocardial infarction).


Q: What research supports the use of Kalpress Cardio for heart rhythm issues?

While heart rhythm disorders are not a primary approved indication, clinical studies have examined the effects of the active ingredient on cardiac complications. This includes the recording of events like atrial fibrillation in high-risk populations such as those with heart failure.


Q: Can I take Kalpress Cardio if I also take supplements like fish oil or magnesium?

Specific interactions with supplements like fish oil or magnesium are not typically listed in regulatory documents. The main cautionary point regarding supplements involves those containing potassium, which must be discussed with a healthcare provider due to the risk of high potassium in the blood.


Q: What should I do if the side effects from Kalpress Cardio don't seem to go away?

Official safety documents advise seeking immediate medical attention for rare, severe reactions such as swelling of the face or throat (angioedema). For common, mild side effects, the advice is to contact a healthcare provider for evaluation if the symptoms persist or become troublesome.


Q: How is the effectiveness of Kalpress Cardio measured by doctors?

Effectiveness is typically assessed by monitoring key clinical results. This includes checking for the achievement of target blood pressure levels, noting any improvement in heart failure symptoms, and tracking changes in laboratory values like albuminuria for diabetic kidney disease.


Q: Is Kalpress Cardio known to interact with caffeine intake?

Specific, major drug-drug interactions with moderate caffeine consumption are generally not listed in official drug interaction databases. Since caffeine can temporarily affect blood pressure, it is generally recommended that patients discuss their typical intake with their healthcare provider.


Q: Are there known side effects of Kalpress Cardio related to sleep?

Yes, official regulatory documents, which list possible adverse reactions, include insomnia (difficulty falling or staying asleep) as a reported side effect of the medication.


Q: If I am taking Kalpress Cardio, can I still drink alcohol moderately?

Alcohol (ethanol) may have additive effects with the medication, potentially causing a greater decrease in blood pressure. This combination is described as potentially increasing the risk of symptoms associated with low blood pressure, such as dizziness or fainting.


Q: How quickly does Kalpress Cardio start working after the very first dose?

The initial blood pressure-lowering effect, known as antihypertensive activity, typically starts approximately two hours after taking the first dose.


Q: Is it normal to feel a mild headache after starting Kalpress Cardio?

Headache is listed in the official adverse reactions section as one of the commonly reported side effects. These mild symptoms are commonly reported as the body adjusts to the medication.


Q: Does the time of day I take Kalpress Cardio matter for its effectiveness?

To maintain a consistent level of the drug in the blood, it is important to take the medication at the same time each day. For certain conditions, the total daily amount may be divided and taken twice daily as directed by the prescribing information.


Q: How does Kalpress Cardio affect heart rate over time?

Official clinical trial data indicates that in treated patients, there was essentially no change in heart rate. The medication primarily works to lower blood pressure, rather than having a direct effect on heart rate over time.


Q: Is there a maximum period of time that Kalpress Cardio can be taken?

The decision on the duration of use is based on the chronic nature of the condition being treated. Studies have documented maintaining the drug's efficacy for periods of up to two years without a loss of clinical effect.


Q: Are there any specific warnings for elderly patients using Kalpress Cardio?

Official documents advise caution for older adults (geriatric patients). Although no initial dose adjustment is usually necessary, monitoring is advised because reduced kidney function, a risk factor for side effects, is more frequent in this population.


Q: What is the most important thing to monitor while taking Kalpress Cardio?

Regulatory documents recommend caution and monitoring for specific risks, especially the potential for Hyperkalemia (high potassium in the blood) and potential worsening of Renal Function (kidney function). These parameters require monitoring by a healthcare professional.


Q: How does the official research describe the long-term prognosis for users of Kalpress Cardio?

Research involved long-term follow-up of patients to assess overall health outcomes. Clinical studies measured major endpoints such as all-cause mortality and major cardiac events in high-risk patient groups, providing data relevant to long-term prognosis.


Q: Does taking Kalpress Cardio affect future surgical procedures?

Angiotensin II Receptor Blockers (ARBs), the class of this drug, are known to potentially cause a sudden drop in blood pressure (hypotension) during surgery. It is important to inform the care team, including the anesthesiologist, that you are taking this medication before any planned procedure.


Q: If a person feels fine, is it still important to continue taking Kalpress Cardio?

Many serious conditions treated by this medication, particularly high blood pressure, often have no obvious symptoms. Even if a person feels fine or experiences no noticeable change, it is generally important to continue taking the medication as prescribed to maintain therapeutic benefit.


Q: Does Kalpress Cardio interact with topical creams or ointments?

Regulatory documents focus on interactions with systemically absorbed medicines (taken by mouth or injection). However, if topical creams or ointments contain interacting substances, such as systemically absorbed NSAIDs, caution may be required, and consultation with a healthcare provider is recommended.


Q: What is the typical timeframe before a doctor reviews the effectiveness of Kalpress Cardio?

Since the maximum blood pressure reduction is typically reached after about four weeks of consistent dosing, this timeframe is often a key milestone for a healthcare provider to review the medication's effectiveness and make any necessary adjustments.


Q: Is it common to feel a little dizzy when first starting Kalpress Cardio?

Dizziness is listed in the official safety information as a very common adverse reaction. It is frequently experienced as the body adjusts to the blood pressure changes, especially when treatment begins.


Q: Can Kalpress Cardio be taken with a standard daily multivitamin?

No specific interaction with standard multivitamins is listed in the official warnings. However, patients should check the label of their multivitamin to ensure it does not contain high amounts of potassium, as potassium supplements are advised against due to hyperkalemia risk.


Q: How long after stopping Kalpress Cardio does the drug usually stay in the system?

The active substance is eliminated in a biphasic manner, with the main amount having an average elimination half-life of approximately 6 hours. This is the time it takes for half of the drug to be removed from the body.


Q: Is it necessary to have regular blood tests while taking Kalpress Cardio?

Yes, regulatory and clinical guidelines state that regular monitoring is necessary in susceptible patients. Blood tests are used to check parameters like serum potassium levels and renal function to identify and manage potential adverse effects.


Q: Is it true that Kalpress Cardio might cause a persistent cough?

Cough is listed as a common adverse reaction in official safety documents, and this side effect was observed in clinical studies. The question of whether the cough is 'persistent' is a matter for discussion with a healthcare provider.


Q: Does Kalpress Cardio interact with any herbal supplements like St. John's wort?

Specific interactions with many herbal remedies are often not fully established in regulatory listings. Official advice is to always inform your healthcare provider about all medicines, supplements, and herbal products you are taking to allow for a comprehensive safety review.


Q: What is the difference between the Kalpress Cardio brand name and a generic version?

The official product information notes that the standard oral tablet and the oral suspension form of the medication are not directly substitutable (not milligram-for-milligram equivalent). A dose adjustment must be made by a healthcare provider when switching between these forms due to differing levels of drug absorption.


Q: What is the official guidance on managing mild side effects of Kalpress Cardio?

Official guidance emphasizes immediate attention for any serious, rare reactions. For more common, mild side effects, the advice is to contact a healthcare provider for individual assessment and advice if the symptoms are persistent or troublesome.


Q: Are there specific instructions for storing Kalpress Cardio safely?

Yes, the tablets must be stored in their original, tightly closed container at room temperature, away from light and moisture. It is essential to always keep this medication out of the sight and reach of children and pets.

Advertisements

How should Kalpress Cardio be stored and disposed of?

Kalpress Cardio tablets should be stored safely in their original, tightly closed container to protect the medicine from light, air, and moisture. Store the medicine at room temperature, typically below 25 C (77 F), and keep it away from excess heat and humidity. Do not store Kalpress Cardio in a bathroom or kitchen cabinet, as these areas often have high temperature or humidity fluctuations.


Always keep this medication out of the sight and reach of children and pets. Taking expired or unused medicine is not safe. To dispose of unneeded or expired Kalpress Cardio, do not flush it down a toilet or pour it down a drain unless specifically instructed to do so by local guidelines or the medication information. The most recommended disposal method is to return it to a local pharmacy or designated drug take-back program. If no take-back program is available, mix the tablets with an unappealing substance, seal the mixture in a plastic bag, and discard it in household trash, after destroying all personal information on the prescription label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Kalpress Cardio found in:

A-Z Index: